Article
Role of MDM2 Overexpression in Doxorubicin Resistance of Breast Carcinoma
1 Feb 1998
Abstract excerpt
Several oncoproteins or tumor suppressor gene products have been indicated to be of value as predictors of the de novo resistance to cytotoxic agents. In this study, we have investigated the role of MDM2 (murine double minutes) overexpression in doxorubicin resistance of breast cancer. Immunocytochemical analysis demonstrated that MDM2-positive tumors, even with p53-negative phenotype, were significantly more...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
